Motley Fool58d agobullish
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3127last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Motley Fool58d agobullish
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?BioPharma Dive58d agoneutral
Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra useInsider Monkey60d agoneutral
Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?GuruFocus.com60d agobullish
Amgen's Imdelltra Sales Surge 115% as Lung-Cancer Combination Meets Major GoalsInvestorsHub60d agoneutral
Amgen, AstraZeneca combination improves survival measures in late-stage lung cancer studyMT Newswires61d agoneutral
US Equity Markets End Lower After Houthi Attack on Saudi Arabia Energy FacilitiesThe Wall Street Journal61d agoneutral
Amgen Stock Poised for Worst Day in More Than Two DecadesMT Newswires61d agobearish
Amgen's Olpasiran May Still Show Heart-Risk Reduction Despite Novartis Miss, UBS Says24/7 Wall St.61d agobearish
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%GuruFocus.com61d agobearish
AstraZeneca Falls Today Even as Imfinzi Wins a Landmark Survival TestSchaeffer's Investment Research61d agoneutral
Novartis Trial Failure Sparks Biopharma Options Frenzy